Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
- Where
- Cincinnati
- Age
- 18 years and over
- People
- 30
- Run by
- The Christ Hospital
See details and how to joinNCT07207395 - No phaseTaking peopleProspective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- Where
- Camden
- Age
- 18 years and over
- People
- 198
- Run by
- Cooper Norcross Health
See details and how to joinNCT05203328 - Phase 1/2Taking peopleA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Where
- Ann Arbor, Boston, Dallas, Houston, Los Angeles, Nashville
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT05941507 - Phase 1Taking peopleA Study of NX-1607 in Adults With Advanced Malignancies
- Where
- Aurora, Chapel Hill, Charlottesville, Chicago, Duarte, Houston, Los Angeles, Oklahoma City, San Francisco, Seattle
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05107674 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Where
- Columbus, Gilbert, Jacksonville, La Jolla, Los Angeles, New York, Rochester, Seattle, St Louis, Tampa
- Age
- 18 years and over
- People
- 240
- Run by
- A2 Biotherapeutics Inc.
See details and how to joinNCT06682793 - Phase 2Taking peopleThoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
- Where
- Rochester
- Age
- 18 years and over
- People
- 48
- Run by
- University of Rochester
See details and how to joinNCT06262321 - No phaseTaking peoplePROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- Where
- Houston
- Age
- 18 years and over
- People
- 7,200
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05049837 - Phase 1Taking peopleA Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Where
- Canton, Cleveland, Houston, Lexington, Orange, Plantation
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06592638 - No phaseTaking peopleClinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Where
- Baltimore, Binghamton, Charleston, Chicago, Deerfield, DeLand, Doral, DuBois, Florence, Gainesville, Grand Forks, Gulfport, Houston, Hyannis, Jackson, Kissimmee, Lancaster, Leawood, Los Angeles, Milwaukee, Mullica Hill, Oklahoma City, Philadelphia, Pierre, Portland, Port Orange, Raleigh, Reno, Sayre, Springfield, Stamford, The Villages, Tyler, Wichita, Winter Park, Wyomissing
- Age
- 50 years and over
- People
- 20,000
- Run by
- Freenome Holdings Inc.
See details and how to joinNCT06122077 - No phaseTaking peopleLung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- Where
- Orange
- Age
- 18 years to 80 years
- People
- 1,753
- Run by
- University of California, Irvine
See details and how to joinNCT07062172 - Early phase 1Not yet taking people in United StatesA Safety Study of 212Pb-Pentixather Radioligand Therapy
- Where
- Iowa City
- Age
- 18 years and over
- People
- 20
- Run by
- Yusuf Menda
See details and how to joinNCT05557708 - Phase 1/2Taking peopleFIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
- Where
- Canton, Nashville, Washington D.C.
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06669117 · EU 2024-512760-64-00 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Boston, Chapel Hill, Hershey, Los Angeles, Madison, Tampa
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - Early phase 1Not yet taking people in United StatesTrial of ctDNA of Guidance to Determine PostOperative Radiation Therapy
- Where
- New Brunswick
- Age
- 18 years to 90 years
- People
- 25
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT06979661 - Phase 1/2Active, not recruitingA Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
- Where
- Orange
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- J Ints Bio
See details and how to joinNCT05394831 - Phase 1/2Taking peopleRAPA-201 Therapy of Solid Tumors
- Where
- Hackensack
- Age
- 18 years and over
- People
- 37
- Run by
- Rapa Therapeutics LLC
See details and how to joinNCT05144698 - Phase 2Taking peopleDefinitive Radiation for High-Risk Spine Metastases
- Where
- Stony Brook
- Age
- 18 years and over
- People
- 26
- Run by
- Stony Brook University
See details and how to joinNCT06165419 - Phase 2Taking peopleOlaparib in Patients With HRD Malignant Mesothelioma
- Where
- Chicago
- Age
- 18 years and over
- People
- 56
- Run by
- University of Chicago
See details and how to joinNCT04515836 - Phase 1Taking peopleA Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
- Where
- Louisville, Nashville, New York, Omaha, Sacramento, Seattle
- Age
- 18 years and over
- People
- 81
- Run by
- Avistone Biotechnology Co., Ltd.
See details and how to joinNCT06046495 - No phaseTaking peopleTemple Health Chest Initiative (THCI 2.0)
- Where
- Philadelphia
- Age
- 50 years to 80 years
- People
- 1,000
- Run by
- Temple University
See details and how to joinNCT06933758 - Phase 3Not yet taking people in United StatesA Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer
- Where
- Decatur
- Age
- 18 years and over
- People
- 154
- Run by
- Cell>Point LLC
See details and how to joinNCT01394679 - No phaseTaking peopleCPRIT: Patient Adherence to Lung Cancer Screening
- Where
- Houston
- Age
- 50 years to 80 years
- People
- 340
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06872723 - No phaseTaking peopleCollection of Sputum and Labeling for Lung Cancer
- Where
- Albuquerque, San Antonio, Summit
- Age
- 21 years and over
- People
- 500
- Run by
- bioAffinity Technologies Inc.
See details and how to joinNCT03457415 - No phaseNot yet taking people in United StatesGenomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
- Where
- New York
- Age
- 18 years to 85 years
- People
- 111 worldwide
- Run by
- Oncology Center of Biochemical Education And Research
See details and how to joinNCT06717243 - No phaseTaking peopleInpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.
- Where
- New York
- Age
- 50 years to 80 years
- People
- 150
- Run by
- Physician Affiliate Group of New York
See details and how to joinNCT06876831